Developing RNAi-Mediated Therapeutics for Fibrolamellar Carcinoma

Principal Investigator: Praveen Sethupathy

Department of Biomedical Sciences

Email: pr46@cornell.edu

Sponsor: Alnylam Pharmaceuticals Inc.

Title: Developing RNAi-Mediated Therapeutics for Fibrolamellar Carcinoma

Project Amount: $55,407

Project Period: December 2021 to December 2022